|
|
|
|
Hepititus C Virus (HCV) is a serious liver disease; it is estimated that about 4 million people in the United States are infected with hepatitis C, which is about 2% of the population. This makes hepatitis C more common than HIV infection. In about 15% of cases, hepatitis C infection is acute, meaning it is cleared spontaneously by the body and there are no long-term consequences. Unfortunately, in the majority of cases (85%), the infection becomes chronic and slowly damages the liver over many years. Over time, this liver damage can lead to cirrhosis (or scarring) of the liver, end-stage liver disease, and liver cancer. This FirstVue Anti-Hepatitis C (Anti-HCV) Rapid Test is a qualitative immunoassay for detecting antibodies in whole blood, serum (best), plasma samples that are specific to the Hepatitis C Antigen. Using the latest in Colloidal Gold Technology (20 times sensitivity). Features & Benefits - Registered Medical Device
- Easy To Use Testing Proceedure for both Men & Women
- Two Simple Steps - Add Sample & Reagent Developer
- Laboratory Accurate Colloidal Gold Technology
- Easy-to-read Color Band Signal with Built-in Test Control
- Confidential Results Results in 10 Minutes
- High Sensitivity & Specificity
- No Additional Instrumentation Required
- For In Vitro Use Only
|
|
|
